Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan Dose Response in Hypertensive Children (6mo-5yr)
NCT00435162Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started Mar 2007; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00435162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435162.